KEY FINDINGS The global stem cell market is evaluated to grow with a CAGR of 7.82%, during the forecast period of 2021 to 2028. Primary factors driving the market growth include the rising demand for stem cells in regenerative medicine, growing awareness about umbilical cord stem cells, surging research and development investments in stem cell therapies and research, and technological advancements.
MARKET INSIGHTS Stem cells possess remarkable potential, in terms of promoting wound repaid in a paracrine manner and cutaneous tissue regeneration.As mesenchymal stem cells, numerous cell types, embryonic stem cells, epithelial stem cells, resident tissue stem cells, hematopoietic stem cells, and adipose-derived stem cells are presently under extensive investigation.
As a result, this is likely to contribute to the significant growth of the stem cell market. Umbilical cord stem cells as a non-invasive and efficacious alternative source of hematopoietic stem cells are gaining added awareness and prevalence.They are primarily utilized for treating a varied range of blood-, metabolic-, bone-, and immune system-related disorders and diseases.
Moreover, the knowledge regarding the importance of the umbilical cord, as well as its applications, especially across developed markets, is steadily increasing.
REGIONAL INSIGHTS The global stem cell market growth analysis includes the Asia Pacific, Europe, North America, and the rest of the world.The Asia Pacific observes an increased incidence of chronic diseases, such as cancer, in addition to growing medical tourism in developing nations like India and China, as well as improved economic stability.
As a result, the region is anticipated to be the fastest-growing market for stem cells.
COMPETITIVE INSIGHTS Since stem cells play a crucial role in toxicology studies and drug discovery, the intensity towards optimizing the technical strength for stem cells is continually growing.This factor is also crucial in bolstering the growth of the companies operating in the market.
Hence, the degree of competitive rivalry is anticipated to increase further, and remain high, over the forecast period. The market’s key players include, Corning Inc, Becton, Dickinson and Company (BD), GE Healthcare, Smith & Nephew PLC, Qiagen NV, etc.
Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Report Synopsis Due to the COVID-19 Pandemic, telehealth and tele-detailing (also called remoter detailing or web calls) have set forth that allow a biosimilars companies’ commercialization branch to have a wide range with less few reps. Also, the fluidity of the labor market is another new dynamic allowing for a greater...
Preimplantation Genetic Testing Market Research Report by Technology (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, Next-Generation Sequencing, Polymerase Chain Reaction, and Single-Nucleotide Polymorphism), by Offering (Instruments Services, Reagents and Consumables, and Software and Services), by Procedure...
Protein Therapeutics Market Research Report by Protein Function (Enzymatic and Regulatory, Protein Diagnostics, and Vaccines), by Product Type (Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, and Insulin) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Enzyme-linked Immunosorbent Assay (ELISA) Testing Market Research Report by Test Type (Competitive ELISA, Indirect ELISA, Multiple and Portable ELISA, and Sandwich ELISA), by Application (Cancer, Immunology, Infectious Diseases, Inflammation, and Protein Quantitation) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market...
Cell Expansion Market Research Report by Product (Consumables and Instruments), by Cell Type (Animal Cells and Human Cells), by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR...
266 pages •
By The Business Research Company
• Dec 2020
Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global Filgrastim Biosimilars market. Description: Where is the largest and fastest growing market...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the interleukin inhibitors market are Sanofi, GlaxoSmithKline, Novartis, Johnson & Johnson, Roche, Eli Lilly, AstraZeneca, Teva Pharmaceutical and Regeneron Pharmaceuticals. The global interleukin inhibitors market is expected to decline from $18.22 billion in 2019 to $17.93 billion in 2020 at a compound annual growth...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to decline from $13.57 billion in 2019 to $12.60 billion...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the biosimilar monoclonal antibodies market are Pfizer, Novartis, Allergan, Coherus BioSciences, Biocon, Amgen, Boehringer Ingelheim, Celltrion, BioXpress Therapeutics, and Intas Pharmaceuticals Limited. The global biosimilar monoclonal antibodies market is expected to decline from $3.21 billion in 2019 to $3.04 billion...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.